Published in J Urol on October 01, 1993
Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. Br J Cancer (1997) 1.21
Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines. Radiat Oncol (2014) 0.79
Significance of neoadjuvant hormonal therapy in radical retropubic prostatectomy: a retrospective single-surgeon study. Yonsei Med J (2013) 0.75
Re: Possible mechanism for seeding of tumor during radical prostatectomy. J Urol (1994) 0.75
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst (1998) 8.33
Epidemic listeriosis associated with Mexican-style cheese. N Engl J Med (1988) 7.75
ACID-BASE EQUIVALENCE OF THE BLOOD IN DISEASES ASSOCIATED WITH HYPERGLOBULINEMIA; WITH SPECIAL REFERENCE TO LYMPHOGRANULOMA INGUINALE AND MULTIPLE MYELOMA. J Clin Invest (1936) 6.18
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol (1999) 4.78
Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res (1987) 4.44
Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer (1978) 4.04
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J Urol (1994) 3.17
Malignant urachal lesions. J Urol (1984) 2.99
Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol (1990) 2.90
To redeem them from death. Reactions of family members to autopsy. Am J Med (1986) 2.84
Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology (1998) 2.78
Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst (1993) 2.76
Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA (1996) 2.74
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Factors predicting recovery of erections after radical prostatectomy. J Urol (2000) 2.44
Risk factors for urinary incontinence after radical prostatectomy. J Urol (1996) 2.42
Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res (1997) 2.35
Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol (1995) 2.19
Pathology and probability. Likelihood ratios and receiver operating characteristic curves in the interpretation of bronchial brush specimens. Am J Clin Pathol (1995) 2.07
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol (1999) 2.00
Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res (1998) 1.95
Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience. J Urol (1980) 1.84
Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. J Urol (1980) 1.80
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol (2000) 1.80
Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer? J Urol (1994) 1.78
Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors. J Clin Invest (1983) 1.77
Serum androgens: associations with prostate cancer risk and hair patterning. J Androl (1997) 1.76
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology (2001) 1.76
Functional consequences of posttranslational isomerization of Ser46 in a calcium channel toxin. Science (1994) 1.73
Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci U S A (2000) 1.73
Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol (1995) 1.63
Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J Pathol (2006) 1.63
Enzymology of long-chain base synthesis by liver: characterization of serine palmitoyltransferase in rat liver microsomes. Arch Biochem Biophys (1984) 1.62
The palpable breast nodule. A cost-effectiveness analysis of alternate diagnostic approaches. Cancer (1993) 1.61
Total prostatoseminal vesiculectomy in the treatment of debilitating perineal pain. J Urol (1992) 1.60
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. J Pharmacol Exp Ther (2008) 1.60
Transient lower extremity neurapraxia associated with radical perineal prostatectomy: a complication of the exaggerated lithotomy position. J Urol (1998) 1.59
Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology. J Urol (1999) 1.54
Testicular metastasis as the first manifestation of colon carcinoma. J Urol (1988) 1.54
Future prospects in prostate cancer. Prostate (1999) 1.53
The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol (1994) 1.53
A catalog of prostate cancer nomograms. J Urol (2001) 1.51
Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer (1997) 1.50
Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol (1982) 1.50
Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology (1994) 1.48
Digestive function after radical pancreaticoduodenectomy. Am J Surg (1969) 1.47
Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study. J Urol (1991) 1.47
Synaptonemal complex complement of man in spreads of spermatocytes, with details of the sex chromosome pair. Science (1975) 1.46
Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J Immunol (2000) 1.45
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology (2000) 1.44
Diphtheria in the United States, 1971-81. Am J Public Health (1985) 1.44
Technology assessment in anatomic pathology. An illustration of test evaluation using fine-needle aspiration biopsy. Arch Pathol Lab Med (1994) 1.44
The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer. J Urol (1989) 1.43
Paclitaxel in advanced urothelial carcinoma: its role in patients with renal insufficiency and as salvage therapy. J Urol (1996) 1.42
Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology (1997) 1.41
Isofenphos induced metabolic changes in K562 myeloid blast cells. Leuk Res (2001) 1.41
A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol (1991) 1.40
Tumors of the kidney, ureter, and bladder. West J Med (1992) 1.39
Effect of methionine and vitamin B-12 on the activities of methionine biosynthetic enzymes in metJ mutants of Escherichia coli K12. Arch Biochem Biophys (1973) 1.39
The effect of benign breast biopsy on subsequent breast cancer detection practices. Oncol Nurs Forum (1994) 1.38
Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol (1980) 1.37
Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase. Neuroscience (2006) 1.37
Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2000) 1.37
Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol (1991) 1.35
Recalled anxiety: from discovery to diagnosis of a benign breast mass. Oncol Nurs Forum (1995) 1.35
Early detection of prostate cancer. Hum Pathol (1992) 1.34
Meningococcal disease in the United States--1986. Meningococcal Disease Study Group. J Infect Dis (1991) 1.34
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol (2000) 1.33
Rupture of the corpus cavernosum: surgical management. J Urol (1983) 1.32
Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med (1987) 1.30
Comparison of broth and human serum as the diluent in the serum bactericidal test. Antimicrob Agents Chemother (1975) 1.28
Human transforming growth factor-alpha stimulates bone resorption in vitro. J Clin Invest (1985) 1.28
Controversial aspects of diagnosis and management of blunt abdominal trauma. Am J Surg (1966) 1.28
PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells. Br J Cancer (2003) 1.28
The significance of biliary pressure in cholangitis. Arch Surg (1969) 1.27
In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. Hum Gene Ther (1999) 1.26
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol (1996) 1.26
A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg (1976) 1.26
Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol (1998) 1.26
Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial. J Urol (1997) 1.25
Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J Urol (1997) 1.24
Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology (1993) 1.23
The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis. J Urol (1977) 1.23
The association of benign prostatic hyperplasia and cancer of the prostate. Cancer (1992) 1.22
Association of p53 mutations with metastatic prostate cancer. Clin Cancer Res (1995) 1.22
Diverticula of the male urethra. J Urol (1980) 1.22
Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Hum Pathol (2001) 1.22
Breast cancer screening knowledge, attitudes, and practices among Korean American women. Oncol Nurs Forum (2001) 1.22
Autopsy: moribund art or vital science? Am J Med (1985) 1.21
Impact of a clinical pathway for radical retropubic prostatectomy. Urology (1998) 1.20
Diagnosis of Kaposi's sarcoma by fine-needle aspiration biopsy. Am J Clin Pathol (1987) 1.19
NCCN Practice Guidelines for Prostate Cancer. Oncology (Williston Park) (2000) 1.19
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines? Br J Pharmacol (2011) 1.19
Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique. Cancer (1977) 1.18
Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol (1994) 1.18